7.4 Outcome of preventive atrial pacing on recurrences of atrial fibrillation

EP Europace ◽  
2003 ◽  
Vol 4 (Supplement_1) ◽  
pp. A12-A12
Author(s):  
S. Janko ◽  
M. Fuller ◽  
T. Matis ◽  
S. Schimmel ◽  
K. Schneider ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Atrial Pacing ◽  
Preventive Atrial Pacing

Prevention of long-lasting atrial fibrillation through antitachycardia pacing in 584 dual-chamber pacemaker patients

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
G Boriani ◽  
Y Sakamoto ◽  
S Iacopino ◽  
S Komura ◽  
P Pieragnoli ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Poor Quality ◽  
World Population ◽  
Atrial Pacing ◽  
Dual Chamber ◽  
Antitachycardia Pacing ◽  
Dual Chamber Pacemaker ◽  
Randomized Evaluation ◽  
Low Incidence ◽  
Preventive Atrial Pacing

Abstract Background Atrial fibrillation (AF) is a frequent arrhythmia in pacemaker patients and is associated with poor quality of life and increased risks of heart failure, dementia, stroke, and death. The MINERVA trial has shown that the combination of 3 pacing algorithms – 1) atrial antitachycardia pacing (aATP), 2) atrial preventive pacing and 3) managed ventricular pacing (MVP) - delays progression to persistent and permanent AF, compared with standard DDDR pacing mode and with MVP mode, in pacemaker patients with AF history. Purpose We performed a comparative non randomized evaluation to confirm the hypothesis that aATP is the main driver of persistent/permanent AF reduction independently on the effect of preventive atrial pacing. Methods Thirty-one Italian and Japanese Cardiology centers included consecutive dual-chamber pacemaker patients with AF history. aATP was programmed in all patients while preventive atrial pacing was not enabled. Comparison was made with all the 3 groups in MINERVA randomized trial. The main endpoint was incidence of AF longer than 7 consecutive days, as detected by device diagnostics. Results A total of 146 patients (73 years old, 54% male) were included and followed for a median observation period of 31 months. The 2-year incidence of AF>7 days was 12% in the aATP group, very similar to that found in the arm of the MINERVA trial with aATP enabled (13.8%, p=0.732) and significantly lower than AF incidence found in the MINERVA Control DDDR arm (25.8%, p=0.012) and in the MINERVA MVP arm (25.9%, p=0.025). Conclusions In a real-world population of dual-chamber pacemaker patients with AF history, use of aATP was associated with low incidence of persistent AF during follow up, highlighting that the positive results of the MINERVA trial are related to the effectiveness of aATP rather than to the effects of preventive atrial pacing. Funding Acknowledgement Type of funding source: None

Local Capture by Atrial Pacing in Spontaneous Chronic Atrial Fibrillation

Circulation ◽  
1997 ◽  
Vol 95 (10) ◽  
pp. 2416-2422 ◽  
Author(s):  
Claudio Pandozi ◽  
Leopoldo Bianconi ◽  
Mauro Villani ◽  
Antonio Castro ◽  
Giuliano Altamura ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Atrial Fibrillation ◽  
Atrial Pacing ◽  
Local Capture

A cool modality to restore sinus rhythm

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
O Yasin ◽  
A Sugrue ◽  
M Van Zyl ◽  
A Ladejobi ◽  
J Tri ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Body Temperature ◽  
Sinus Rhythm ◽  
Animal Experiments ◽  
Funding Source ◽  
Atrial Pacing ◽  
Exact Test ◽  
Chi Squared ◽  
Cool Device ◽  
Atrial Defibrillation

Abstract Background Slowing electrical conduction by cooling the myocardium can be used for defibrillation. We previously demonstrated the efficacy of a small cold device placed in oblique sinus (OS) in terminating atrial fibrillation (AF). However, the parameters needed to achieve effective atrial defibrillation are unknown. Purpose Assess effect of the size of cooled myocardium on frequency of AF termination in acute canine animal models. Methods Sternotomy was performed under general anesthesia in 10 acute canine experiments. AF was induced using rapid atrial pacing and intra-myocardial epinephrine and acetylcholine injections. Once AF sustained for at least 30s, either a cool (7–9°C) or placebo (body temperature) device was placed in the OS. Four device sizes were tested; ½X½, ¾X¾, and 1X1 inch devices and two ¾X¾ inch devices placed side by side simultaneously. Time to AF termination was recorded. Chi-squared or Fisher's exact test were used to compare the frequency of arrhythmia termination with cooling versus placebo. Results A total of 166 applications were performed (89 cool vs 77 placebo) in 10 animal experiments. Overall, AF terminated in 82% of the cooling applications vs. 67.5% of placebo (P=0.03, Figure 1). For the ½X½ inch device 88% of cold applications restored sinus rhythm vs. 63.6% for placebo (P=0.05). The frequency of sinus restoration for cold ¾X¾, 1X1 and two ¾X¾ side by side devices was 86.7%, 83.3% and 70% respectively. Time to sinus restoration when achieved was within three minutes was also not significantly changed. Conclusion Placing a cool device in the oblique sinus can terminate AF and efficacy is not affected by the size of device. Funding Acknowledgement Type of funding source: Private grant(s) and/or Sponsorship. Main funding source(s): MediCool Technologies

scholarly journals Distribution of atrial electrogram types during atrial fibrillation: Effect of rapid atrial pacing and intercaval junction ablation

1996 ◽  
Vol 27 (7) ◽  
pp. 1713-1721 ◽  
Author(s):  
Huagui Li ◽  
John Hare ◽  
Kashef Mughal ◽  
David Krum ◽  
Michael Biehl ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Atrial Pacing ◽  
Atrial Electrogram

scholarly journals Prospective Randomized Study to Assess the Efficacy of Site and Rate of Atrial Pacing on Long-Term Progression of Atrial Fibrillation in Sick Sinus Syndrome

Circulation ◽  
2013 ◽  
Vol 128 (7) ◽  
pp. 687-693 ◽  
Author(s):  
Chu-Pak Lau ◽  
Ngarmukos Tachapong ◽  
Chun-Chieh Wang ◽  
Jing-feng Wang ◽  
Haruhiko Abe ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Sick Sinus Syndrome ◽  
Randomized Study ◽  
Prospective Randomized Study ◽  
Atrial Pacing

Effect of atrial pacing on ventricular rate during atrial fibrillation. A human study

2008 ◽  
Vol 9 (3) ◽  
pp. 256-262
Author(s):  
Alessandro Capucci ◽  
Giovanni Quinto Villani ◽  
David Igel ◽  
Tiziana Marotta
Keyword(s):  
Atrial Fibrillation ◽  
Human Study ◽  
Ventricular Rate ◽  
Atrial Pacing

scholarly journals Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation

2018 ◽  
Vol 19 (1) ◽  
pp. 147032031875526 ◽  
Author(s):  
Xuewen Wang ◽  
Guangping Li
Keyword(s):  
Atrial Fibrillation ◽  
Sodium Current ◽  
Renin Angiotensin System ◽  
Canine Model ◽  
Atrial Pacing ◽  
Chain Reaction ◽  
Patch Clamp Technique ◽  
Angiotensin System ◽  
Whole Cell Patch Clamp ◽  
Polymerase Chain

Introduction: Activation of the renin-angiotensin system (RAS) plays an important role in atrial electrical remodeling (AER). The purpose of the present study was to evaluate the effects of irbesartan on cardiac sodium current (INa) in a canine model of atrial fibrillation. Materials and methods: Eighteen dogs were randomized into sham, pacing or pacing+irbesartan groups ( n = 6 in each group). The dogs in the pacing and irbesartan group were paced at 500 bpm for two weeks. Irbesartan (60 mg·kg−1·d−1) was administered orally in the pacing+irbesartan groups. INa was recorded using the whole-cell patch clamp technique from canine atrial myocytes. The expressions of cardiac Na+ channels (Nav1.5) mRNA were semi-quantified by reverse transcription-polymerase chain reaction. Results: Our results showed that INa density and Nav1.5 mRNA expression in the pacing group decreased significantly ( p < 0.05 vs. sham). However, rapid atrial pacing had no effects on the half-activation voltage (V1/2act) and half-inactivation voltage (V1/2inact) of INa ( p > 0.05 vs. sham). Irbesartan significantly increased INa densities and gene expression and hyperpolarized V1/2act without concomitant changes in V1/2inact. Conclusions: Irbesartan significantly increased INa densities, which contributed to improving intra-atrial conduction and prevented the induction and promotion of AF in atrial pacing dogs.

Sign in / Sign up

Export Citation Format

Share Document